Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An approach to estimating tuberculosis incidence and case detection rate from routine notification data.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2015
Same author

[The ocular tuberculosis epidemic situation in the Sverdlovsk Region].

Tuberkulez i bolezni legkikh·2009
Same author

[To the program on state guarantees to deliver free medical aid to Russia's citizens in tuberculosis facilities].

Problemy tuberkuleza i boleznei legkikh·2008
Same author

[Monitoring of tuberculosis recurrences: their causes and precipitating factors].

Problemy tuberkuleza i boleznei legkikh·2008
Same author

[Female tuberculosis morbidity and mortality in the Sverdlovsk Region].

Problemy tuberkuleza i boleznei legkikh·2008
Same author

[Hospital-replacing technologies in the treatment and rehabilitation of patients with pulmonary tuberculosis].

Problemy tuberkuleza i boleznei legkikh·2007

Related Experiment Video

Updated: Jul 28, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

[Effectiveness of tuberculosis vaccines].

O B Nechaeva, V A Arenskiĭ

    Problemy Tuberkuleza
    |May 8, 2001
    PubMed
    Summary

    BCG revaccination in children, including tuberculin diagnosis, is increasing in the Sverdlovsk Region. While tuberculosis incidence remains low, minor forms are rising, yet primary infections are significantly reduced.

    Area of Science:

    • Pediatrics
    • Immunology
    • Public Health

    Background:

    • BCG revaccination is administered thrice in the Sverdlovsk Region: at ages 5, 10, and 15.
    • Coverage for tuberculin diagnosis and BCG vaccination among children is progressively increasing.
    • Complications associated with BCG vaccination have remained consistent over time.

    Purpose of the Study:

    • To evaluate the trends in BCG revaccination coverage and tuberculosis incidence in children in the Sverdlovsk Region.
    • To assess the impact of vaccination programs on tuberculosis primary infection rates.
    • To analyze the patterns of tuberculosis morbidity, including minor forms, in the pediatric population.

    Main Methods:

    • Retrospective analysis of vaccination and tuberculosis incidence data in the Sverdlovsk Region.

    More Related Videos

    Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
    06:38

    Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

    Published on: December 8, 2023

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
    06:26

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

    Published on: July 28, 2023

    Related Experiment Videos

    Last Updated: Jul 28, 2026

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
    06:32

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

    Published on: September 19, 2016

    Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
    06:38

    Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

    Published on: December 8, 2023

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
    06:26

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

    Published on: July 28, 2023

  • Monitoring of BCG revaccination schedules and coverage rates.
  • Epidemiological surveillance of tuberculosis cases in children.

    • Main Results:

    • Increasing trends observed in tuberculin diagnosis and BCG vaccination coverage.
    • BCG vaccination complication rates have remained stable.
    • Pediatric tuberculosis morbidity is rising, primarily due to minor forms.
    • Tuberculosis incidence in children is half the national average.
    • Primary tuberculosis infection rates are 4.5 times lower than expected.

    Conclusions:

    • The BCG vaccination program in the Sverdlovsk Region demonstrates high and increasing coverage.
    • Despite a rise in minor tuberculosis forms, the overall incidence and primary infection rates in children remain significantly lower than national averages.
    • The vaccination strategy appears effective in controlling severe forms of tuberculosis and primary infections in the pediatric population.